Breakthrough cancer drug venetoclax approved for use in Australia
Tuesday, 10 January 2017
New anti-cancer drug, venetoclax which has the power to ‘melt away’ advanced forms of chronic lymphocytic leukaemia (CLL) was recently granted approval by the Australian Therapeutic Goods Administration (TGA).
The drug will be marketed as VenclextaTM and is approved for Australians with relapsed or refractory CLL with 17p
Holden donates 17 Commodores to help Australians get to life-saving treatment
Sunday, 29 October 2016
Finding a way to attend vital appointments can be an added burden to someone already facing a life-threatening blood cancer diagnosis.
Holden are helping to alleviate this stress and provide better journeys to treatment by supplying the Leukaemia Foundation’s nationwide Patient Transport Program with 17 new Commodores.
Streamlined approvals to improve access to lifesaving medicines
Tuesday, 25 October 2016
The Leukaemia Foundation welcomes the Australian Government’s commitment to new reforms to improve the way medicines are accessed for use in Australia.
By helping to streamline access to medicines and medical devices including access to novel and life-saving therapies, the reforms aim to strike a balance by
Building of Hope opens
Friday, 30 September 2016
The Leukaemia Foundation was thrilled to officially open the doors to the Building of Hope, the new Victorian Patient Accommodation Centre on Wednesday July 13.
The occasion was marked by an official ribbon cutting ceremony, attended by the Minister for Health, Hon Jill Hennessy. Minister Hennessy was given
Towards better treatment outcomes in lymphoma by personalising medicine
Thursday, 01 September 2016
New directions in treatment for lymphoma are increasingly based on ‘personalised medicine’, which means identifying the best treatment for an individual patient.
The Leukaemia Foundation’s Head of Blood Cancer Support, Anthony Steele, said the overall aim of this approach was to optimise treatment outcomes.
“Currently, we do not
Targeted therapies offer fresh hope for AML
Friday, 22 July 2016
The results of a clinical trial involving a new combination therapy of Venetoclax and chemotherapy are providing hope for Australians diagnosed with AML
Clinical and translational AML researcher, Dr Andrew Wei and his teams at the Alfred Hospital and Monash University, are optimistic about the combination therapy,
High-tech scans spare lymphoma patients intensive chemo
Monday, 27 June 2016
The use of PET scans can spare Hodgkin lymphoma (HL) patients from the serious effects of chemotherapy thanks to a study supported by the Leukaemia Foundation*.
Results of a study, published in the New England Journal of Medicine, found PET scan imaging can predict treatment outcomes and can
Car racing greats make comeback!
Tuesday, 10 May 2016
For the first time in years some of Australia’s well-known Bathurst racing greats will hit the track again, all for a good cause.
Although many would relish the opportunity to see the likes of Peter Brock, Allan Moffat and John Goss return to the road, it is
33,000 hands needed to knock off cancer
Friday, 15 April 2016
The Leukaemia Foundation has launched a state-wide search for 16,500 pairs of hands to knock on doors, ring doorbells and ask Queenslanders to help open the door to a blood cancer cure.
Alarming new figures from the Australian Bureau of Statistics reveal Queensland blood cancer deaths are
Queensland blood cancer deaths highest in a decade
Tuesday, 08 March 2016
The number of Queenslanders dying from blood cancer has reached its highest point since 2005, according to new statistics released today (March 08).
Latest data from the Australian Bureau of Statistics show 837 people in Queensland died from leukaemia, lymphoma, myeloma or a related blood disorder in